• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Comparison of Airborne SARS-CoV-2 Omicron and Pre-Delta Variants Around Infected Patients

tetano

Editor, Senior Moderator
J Med Virol


. 2025 Feb;97(2):e70258.
doi: 10.1002/jmv.70258. Comparison of Airborne SARS-CoV-2 Omicron and Pre-Delta Variants Around Infected Patients

Carl-Johan Fraenkel[SUP] 1 2 [/SUP], Sara Thuresson[SUP] 3 [/SUP], Patrik Medstrand[SUP] 4 [/SUP], Malin Alsved[SUP] 3 [/SUP], Jakob Löndahl[SUP] 3 [/SUP]



Affiliations
Abstract

Transmissibility has increased during the evolution of SARS-CoV-2, possibly by improved airborne transmission. An increased transmission was noted also in many hospitals. We analyzed SARS-CoV-2 in room air of hospitalized Omicron infected patients and compared results with previous findings with pre-Delta variants to study if SARS-CoV-2 was more prevalent in patient rooms after the introduction of Omicron. Only 4 of 75 (5%) air samples, from 3 of 43 included patients, were positive during the early Omicron wave, compared to 14/120 (12%), from 10 of 60 included patients during the initial wave. No certain statistical difference between virus variants could be established, but the tendency was a lower occurrence at Omicron infected patients, also when adjusting for relevant confounders. These finding do not support the initial hypothesis that increased SARS-CoV-2 aerosol emission from diagnosed patients with Omicron could explain any increased risk of hospital transmission.

Keywords: Omicron; SARS‐CoV‐2; aerosol; aerosol generating procedures; air; transmission.

 
Back
Top Bottom